Ophthalmic Research Center
Tehran, Iran
NCT Number: NCT03922347
This study is a community trial that aims to establish and evaluate an mHealth screening and promotional tool for improving eye health in Iran. Sampling frame is a region in Tehran province with around 1 million sub-urban and rural inhabitants. investigators have obtained the list of health centers and their underserved population from the health authorities. In this region, health services are delivered through rural health houses, urban health posts and overhead health centers (221 units in total). investigators choose 27 units using cluster random sampling method with a probability proportional to size strategy, then investigators randomly assign them into three arms (explained below). The interventions will be at community level with the community as the unit of randomization.
Arm 1- Training of the Primary Health Care (PHC) workers + PHC workers will be empowered with the mHealth tool to monitor, screen and promote community members Arm 2- PHC system will be strengthened with health promotion and screening programmes (same content as the mHealth tool) and PHC workers will deliver eye health messages and screening tests by the conventional facilities.
Arm 3: Control group: only observation and registering of routine care
Looking for future studies?
Notify Me50 year and older
All sexes
Interventional
Phase 3
Tehran, Iran
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
visual acuity test by Snellen chart, fundus imaging by fundus photography (Visucam Pro NM; Carl Zeiss Meditec AG, Germany)
Peek Acuity and Peek Retina installed on smart phones (Samsung Galaxy S8)
Time frame: 6-12 months
Questionnaire based on closed questions
Time frame: At baseline
Peek Acuity Software installed on smart phones (Samsung Galaxy S8, based on Logarithm Minimum Angle of Resolution, LogMAR). Visual acuity will be presented in range (minimum to maximum).
Higher value of visual acuity represents the worsened outcome.
Time frame: At baseline
Peek Retina Software installed on smart phones (Samsung Galaxy S8; based on Logarithm Minimum Angle of Resolution, LogMAR). Higher value of visual acuity represents the worsened outcome.
Time frame: At baseline
visual acuity test by Snellen chart
Time frame: At baseline
fundus photography (Visucam Pro NM; Carl Zeiss Meditec AG, Germany)
Shahid Beheshti University of Medical Sciences
Other
Modelling and Evaluation of a Community-oriented mHealth-based Screening and Promotional Programme for Improving Eye Health in Iran
Acronym: Vison mHealth
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07641127
Behavior, Eye Diseases
Cairo, Egypt
View Trial DetailsNCT06616051
Eye Diseases, Nervous System Diseases
Rawalpindi, Punjab Province, Pakistan
View Trial DetailsNCT07206654
Age-related Macular Degeneration (AMD), Arthralgia
Banī Suwayf, Beni Suweif Governorate, Egypt
View Trial DetailsNCT03174314
Eye Diseases, Nervous System Diseases
New York, United States
View Trial Details